iRadimed Corp (NAS:IRMD)
$ 56.2 3.46 (6.56%) Market Cap: 712.25 Mil Enterprise Value: 616.94 Mil PE Ratio: 38.49 PB Ratio: 8.53 GF Score: 96/100

Q3 2019 IRadimed Corp Earnings Call Transcript

Oct 30, 2019 / 03:00PM GMT
Release Date Price: $25.3 (+5.68%)
Operator

Ladies and gentlemen, thank you for standing by. Welcome to IRADIMED Corporation Third Quarter 2019 Financial Results Conference Call. (Operator Instructions) As a reminder, this conference call is being recorded today, October 30, 2019, and contains time-sensitive information that is accurate only as of today.

Earlier, IRADIMED released financial results for the third quarter 2019. A copy of this press release announcing the company's earnings is available under the heading News on their website at iradimed.com. A copy of the press release was also furnished to the Securities and Exchange Commission on Form 8-K and can be found at sec.gov. This call is being broadcast live over to the Internet on the company's website at iradimed.com, and a replay of the call will be available on the website for the next 90 days.

The agenda for today's call will be as follows: Leslie McDonnell, President and Chief Executive Officer of IRADIMED, will present opening comments; then Brent Johnson, IRADIMED's Executive Vice President of Worldwide Sales and Marketing, will discuss customer orders; and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot